National IBD Co-Learning Initiative to Be Launched by CCFA, RMEI Medical Education

National IBD Co-Learning Initiative to Be Launched by CCFA, RMEI Medical Education
The Crohn’s & Colitis Foundation of America (CCFA) and RMEI Medical Education are set to launch a new nationwide continuing medical education (CME) curriculum, titled “Clinical Convergence: Patient and Provider Perspectives in IBD,” in September. CCFA, the nonprofit whose mission is to cure Crohn’s disease and ulcerative colitis (UC), and RMEI, one of the longest operating medical education companies in the U.S., are currently preparing the initiative’s first edition for patients and providers on improved collaborative management and communication concerning inflammatory bowel diseases (IBD). The program includes two part-time conferences for patients and clinicians, and an interactive online course. "As the leading advocate for patients with IBD and the clinicians who care for them, CCFA is excited to share this innovative approach to education with our member community," said Laura Wingate, CCFA’s vice president of patient and professional services, in a press release. "By bringing patients into the educational discourse with clinicians, our goal is to stimulate a more informed and collaborative approach to IBD management." Crohn’s disease and UC, known collectively as IBD, are estimated to affect one in every 200 people. They are painful diseases, with no known cure, that attack the digestive system – Crohn’s will attack anywhere along the digestive tract and UC may cause inflammation in the large intestine (colon). Symptoms often include abdominal pain, persistent diarrhea, rectal bleeding, fever, and weight loss. Many patients require several hospital visits or even surgery. Most patients develop the disease between the ages of 15 and 35. AbbVie, Takeda Pharmaceuticals U.S.A., and UCB will support the project with independent
Subscribe or to access all post and page content.